|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.37 USD | -2.46% |
|
-2.89% | -14.98% |
VistaGen Therapeutics, Inc. announced that it has appointed Jerry Gin, Ph.D., MBA to its Board of Directors. Dr. Gin has also been appointed as a member of the Company's Audit Committee. Dr. Gin has over 45 years of experience in the healthcare industry, focusing on founding and developing pharmaceutical, diagnostic and biotechnology companies.
He is currently the co-founder and CEO of Nuvora, Inc.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.98% | 118M | |
| +3.91% | 109B | |
| +10.87% | 105B | |
| +1.28% | 22.25B | |
| -13.14% | 22.09B | |
| -7.05% | 18.68B | |
| -38.36% | 17.58B | |
| -10.66% | 16.85B | |
| +3.75% | 13.76B | |
| +36.70% | 12.46B |
VISTAGEN THERAPEUTICS, INC. 
